Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 1/20 | 0.39 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | USP7 | Q93009 | 3/20 | 0.37 |
| ▸ | USP47 | Q96K76 | 2/20 | 0.37 |
| ▸ | DTYMK | P23919 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6209266 | 1.00 | SLC9A1 (0.39) | SLC9A1VCAM1CA12CA9LMNA | |
| SCHEMBL5235575 | 0.83 | LMNA (0.37) | SLC9A1VCAM1CA12CA9LMNA | |
| SCHEMBL5235571 | 0.83 | LMNA (0.37) | SLC9A1VCAM1CA12CA9LMNA | |
| SCHEMBL3902768 | 0.83 | DTYMK (0.51) | VCAM1LMNADTYMKALDH1A1GPR35 | |
| SCHEMBL9744165 | 0.81 | CA12 (0.50) | SLC9A1VCAM1CA12CA9LMNA | |
| SCHEMBL8138894 | 0.75 | VCAM1 (0.46) | SLC9A1VCAM1LMNAALDH1A1GPR35 | |
| SCHEMBL11614707 | 0.75 | TSHR (0.49) | VCAM1LMNADTYMK | |
| SCHEMBL2977714 | 0.74 | DTYMK (0.50) | SLC9A1VCAM1CA12CA9LMNA | |
| SCHEMBL2894347 | 0.74 | DTYMK (0.50) | VCAM1CA12CA9DTYMKALDH1A1 | |
| SCHEMBL4511665 | 0.74 | KMT2A (0.54) | SLC9A1VCAM1LMNAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1603914-A1 | COMPOUNDS HAVING ACTIVITY AT 5HT2C RECEPTOR AND USES THEREOF | GLAXO GROUP LIMITED (GB) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004081010-A1 | COMPOUNDS HAVING ACTIVITY AT 5HT2C RECEPTOR AND USES THEREOF | GLAXO GROUP LIMITED (GB) | 2004-09-23 | — | — | WO | disclosed |